Inogen, the Goleta-based maker of direct-to-consumer respiratory products, on April 27 reported fourth-quarter profit of $1.5 million. The company said it had net income of 7 cents per share. Earnings, adjusted for pretax gains, were 6 cents per share. Inogen, which produces oxygen concentrators for patients suffering from chronic respiratory conditions, posted revenue of $29.1 Read More →Read More →
Loading...You are here: Home > 'Zack Investment Research'